Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2021/12/10 申報
- 申報編號
- 0001209191-21-069159
- 申報時間
- 2021/12/10
- 交易日
- 2021/12/8-12/9
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $23.7 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/8 | Class A Common Stock | M行使選擇權取得 | +28,646 | $2.47 | +$70,755.62 | 28,646 | 直接 | |
| 2021/12/8 | Class A Common Stock | S賣出處分 | −5,176 | $20.03F2 | −$103,675.28 | 23,470 | 直接 | |
| 2021/12/8 | Class A Common Stock | C轉換取得 | +5,488 | $0.00 | $0 | 28,958 | 直接 | |
| 2021/12/8 | Class A Common Stock | S賣出處分 | −5,488 | $20.26F4 | −$111,186.88 | 23,470 | 直接 | |
| 2021/12/9 | Class A Common Stock | C轉換取得 | +1,086 | $0.00 | $0 | 24,556 | 直接 | |
| 2021/12/9 | Class A Common Stock | S賣出處分 | −1,086 | $20.01F5 | −$21,730.86 | 23,470 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/8 | Class A Common Stock | M行使選擇權處分 | −28,646 | $0.00 | $0 | 1,471,354 | 直接 | |
| 2021/12/8 | Class A Common Stock | C轉換處分 | −5,488 | $0.00 | $0 | 8,195,728 | 直接 | |
| 2021/12/9 | Class A Common Stock | C轉換處分 | −1,086 | $0.00 | $0 | 8,194,642 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction, representing a sale to cover the exercise price and related tax withholdings for 28,646 option shares, was executed in multiple trades at prices ranging from $20.014 to $20.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $20.00 to $20.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。